"Link Between Statins and Type 2 Diabetes: Time for a Practice Shift?"
A recent study analyzed the risks associated with different statins and found that while both rosuvastatin and atorvastatin effectively prevented heart attacks and strokes, rosuvastatin was associated with a higher incidence of new-onset type 2 diabetes (T2D) and cataract surgery. However, experts caution that the study's open-label nature and suboptimal dosing of statins limit the interpretation of the findings. They emphasize that the cardiovascular benefits of statins generally outweigh the small increased risks of T2D, and recommend shared decision-making between patients and healthcare providers, considering individual risk factors and lifestyle interventions. Further research is needed to determine the reversibility of statin-associated diabetes and the potential benefits of intermittent statin use.
